These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38140359)
1. The Effects of ESC/ESH-Based Written Generic Lifestyle Advice and a Nutraceutical on 24-Hour Blood Pressure in Patients with High-Normal Office Blood Pressure and Low-Moderate Cardiovascular Risk. Landolfo M; Spannella F; Poliseno C; Massacesi A; Giulietti F; Festa R; Cavazzin E; Sasso G; Mazza A; Sarzani R Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140359 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations. Landolfo M; Allevi M; Spannella F; Giulietti F; Gezzi A; Sarzani R High Blood Press Cardiovasc Prev; 2023 Nov; 30(6):551-560. PubMed ID: 37902917 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals. Brunner HR; Arakawa K Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250 [TBL] [Abstract][Full Text] [Related]
4. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Naser N; Dzubur A; Durak A; Kulic M; Naser N Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288 [TBL] [Abstract][Full Text] [Related]
5. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
6. Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension. Tocci G; Presta V; Ferri C; Redon J; Volpe M High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):51-59. PubMed ID: 31916207 [TBL] [Abstract][Full Text] [Related]
7. Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension. Kim BK; Rhee MY Healthcare (Basel); 2020 May; 8(2):. PubMed ID: 32375221 [TBL] [Abstract][Full Text] [Related]
8. Role of blood pressure monitoring in non-pharmacological management of hypertension. Kawano Y Blood Press Monit; 2002 Feb; 7(1):51-4. PubMed ID: 12040244 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure phenotypes based on ambulatory monitoring in a general middle-aged population. Lin YT; Lampa E; Fall T; Engström G; Sundström J Blood Press; 2021 Aug; 30(4):237-249. PubMed ID: 33797315 [TBL] [Abstract][Full Text] [Related]
10. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220 [TBL] [Abstract][Full Text] [Related]
11. Adequacy of blood pressure control in high-risk hypertensive patients: The DEGREE study. Zeijen VJM; Lafeber M; Versmissen J; Kroon AA; Boersma E; Daemen J Int J Cardiol; 2022 Apr; 352():137-143. PubMed ID: 35176408 [TBL] [Abstract][Full Text] [Related]
12. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study. Lehmann MV; Zeymer U; Dechend R; Kaiser E; Hagedorn I; Deeg E; Senges J; Schmieder RE Int J Cardiol; 2013 Oct; 168(3):2255-63. PubMed ID: 23474245 [TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Hansen TW; Jeppesen J; Rasmussen S; Ibsen H; Torp-Pedersen C Am J Hypertens; 2006 Mar; 19(3):243-50. PubMed ID: 16500508 [TBL] [Abstract][Full Text] [Related]
14. Possible cardiovascular risks of white coat hypertension: updated. Chrysant SG Postgrad Med; 2023 Jun; 135(5):466-471. PubMed ID: 37161879 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients. Korogiannou M; Sarafidis P; Theodorakopoulou MP; Alexandrou ME; Xagas E; Boletis IN; Marinaki S Am J Nephrol; 2021; 52(7):548-558. PubMed ID: 34311458 [TBL] [Abstract][Full Text] [Related]
16. Effects of physical exercise on clinic and 24-hour ambulatory blood pressure in young subjects with mild hypertension. Vriz O; Mos L; Frigo G; Sanigi C; Zanata G; Pegoraro F; Palatini P; J Sports Med Phys Fitness; 2002 Mar; 42(1):83-8. PubMed ID: 11832879 [TBL] [Abstract][Full Text] [Related]
17. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals. Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710 [TBL] [Abstract][Full Text] [Related]
18. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]